Status:
WITHDRAWN
A Study of ResCure™ to Treat COVID-19 Infection
Lead Sponsor:
ProgenaBiome
Collaborating Sponsors:
Rinati Skin, LLC
Conditions:
COVID
Covid-19
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.
Detailed Description
In this Phase I open-label interventional study we will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection. Patients being treated will have severe respiratory symptoms...
Eligibility Criteria
Inclusion
- Critically ill patients with SARS from COVID-19 infection on respirators OR
- Patients with SARS from COVID-19 infection prior or after being placed on respirator
- Male or female patients 18 years of age and older
Exclusion
- 1\. Patients less than 18 years of age
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04395716
Start Date
January 1 2020
End Date
November 1 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ProgenaBiome
Ventura, California, United States, 93003